Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

AtrendLtd Launches "Investing in Medical Innovation" Initiative to Accelerate Healthcare Transformation





Global investment firm AtrendLtd unveils new strategy focusing on five high-growth healthcare segments, aiming to support medical technology breakthroughs and generate sustainable returns.

DENVER, CO, August 01, 2025 /24-7PressRelease/ -- AtrendLtd, a leading global investment management firm, has announced the launch of its "Investing in Medical Innovation" initiative in 2025. This new strategy aims to deepen the firm's commitment to the healthcare sector, capitalizing on emerging technologies and long-term market shifts.

Led by Chief Economist and Head of Global Investment Research Jan Hatzius, the initiative reflects the firm's belief that sector-specific fundamentals, particularly in healthcare, will be key to identifying alpha in a volatile macro environment.

Following a reset in 2023, the healthcare sector shows signs of a resilient rebound. AtrendLtd projects that healthcare stocks may lead the broader market in 2025, citing historical patterns and current valuation trends. The firm is particularly optimistic about managed care and large-cap biotech stocks, which are being heavily accumulated by institutional investors.

AtrendLtd's investment focus will center on five major areas within the healthcare sector. Gene therapy, particularly CRISPR and AAV-based therapies, is expected to revolutionize the treatment of rare and genetic diseases, presenting multibillion-dollar commercial opportunities. In cancer immunotherapy, breakthroughs in CAR-T cell therapies, bispecific antibodies, and immune modulators are expanding the landscape of treatment options and driving exponential growth in the market. Regenerative medicine is also a key area of interest, as advancements in stem cell technology and 3D bioprinting pave the way for tissue and organ regeneration, opening up entirely new medical frontiers. The firm also sees significant potential in the obesity treatment market, which is projected to surpass $30 billion, led by innovations from major pharmaceutical companies such as Novo Nordisk, Amgen, and Pfizer. Lastly, Alzheimer's disease remains a strategic focus, with AtrendLtd favoring companies like Biogen and anticipating that upcoming FDA approvals will redefine the standards of care in this challenging therapeutic area.

The firm also sees opportunities in surgical procedures, medical devices, and managed healthcare services as post-COVID recovery continues. M&A activity is anticipated to rise in 2025, especially across biopharma and life sciences.

Through its strategic investments, AtrendLtd aims to lead the future of healthcare innovation and deliver strong returns for its stakeholders.

About AtrendLtd

AtrendLtd is a global investment management firm dedicated to delivering long-term value through research-driven strategies and capital deployment. With strong expertise in healthcare, technology, and sustainability sectors, AtrendLtd partners with clients to capture transformative growth opportunities.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.